|
| Tendering and Bidding Information->Investment Information |
| China Merchants Zhejiang Asia-Pacific Pharmaceutical Drugs |
| 2007-11-30 21:58:40 |
|
(has been browse 399 times)
|
| Zhejiang Pharmaceutical for the Asia-Pacific business development needs, investment in Shanxi is to, I hope that the pharmaceutical companies interested individuals and companies can Acting my company's products, my company main products are as follows: 1 generic drugs: 1 subsets of the Greek, 2 - messing, 3 to 6, 4 to 4, 5 cefradine, 6 clindamycin, 7 metformin tablets, 8 Chlorine Tablets, 9-tim Seoul heart, 10 ciprofloxacin tablets, 11 propafenone tablets, 12 hypoglycemic Ling, 13 Ofloxacin Tablets, 14 ceftriaxone sodium, 15 cefoperazone sodium, 16 cefazolin sodium, 17 cefotaxime sodium, 18 acyclovir. The new drugs: 1 gatifloxacin, 2 cefpodoxime fat, 3 injection ofloxacin, 4 Doyle (national category), 5 ribavirin 6 etodolac tablets 7 injection Ganciclovir 8 (spore piperazine-sodium and sulbactam sodium 1:1) 9 Bao Er-Lin, 10 Linmaixin (dimethylamino |
|
|
Investment Information
